Market Place
Sourcing Support
Cytokinetics Starts Comet-HF Ph 3 Trial for Heart Failure Treatment
03 Dec 2024 //
GLOBENEWSWIRE
U.S. FDA declines to approve Cytokinetics` heart drug
01 Mar 2023 //
REUTERS
Cytokinetics` heart drug fails to secure FDA panel`s support
14 Dec 2022 //
REUTERS
FDA staff reviewers flag safety concerns over Cytokinetics` heart drug
10 Dec 2022 //
REUTERS
Cytokinetics Announces Availability of Documents for FDA Meeting on Omecamtiv Mecarbil
09 Dec 2022 //
GLOBENEWSWIRE
Cytokinetics Announces Date for FDA Meeting to Review NDA for Omecamtiv Mecarbil
24 Jun 2022 //
GLOBENEWSWIRE
Cytokinetics Provides Regulatory Update Related to NDA for Omecamtiv Mecarbil
17 May 2022 //
GLOBENEWSWIRE
Cytokinetics` heart drug fails a phase 3 as it awaits FDA nod
16 Feb 2022 //
FIERCEBIOTECH
Cytokinetics Announces FDA Acceptance of NDA for Omecamtiv Mecarbil
04 Feb 2022 //
GLOBENEWSWIRE
Cytokinetics, Royalty partner on heart failure drug for $450M
08 Jan 2022 //
ENDPTS
Cytokinetics and JI XING Announce Expansion of Collab to Include Licensing
20 Dec 2021 //
GLOBENEWSWIRE
Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF
12 Sep 2021 //
GLOBENEWSWIRE
Cytokinetics Announces Results From REDWOOD-HCM and GALACTIC-HF
31 Aug 2021 //
GLOBENEWSWIRE
Cytokinetics Completed Enrollment in 2nd Ph3 Trial of Omecamtiv Mecarbil
15 Jun 2021 //
GLOBENEWSWIRE
Amgen to transition devP& commercial rights for omecamtiv mecarbil
24 Nov 2020 //
PHARMABIZ
Amgen kicks heart failure med back to Cytokinetics after `GALACTIC` flop
24 Nov 2020 //
FIERCEBIOTECH
FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure
08 May 2020 //
PRESS RELEASE
Oramed Reports +VE Results in the Final Cohort of Its Ph2b Oral Insulin Trial
26 Feb 2020 //
PR NEWSWIRE
Cytokinetics Announces Design Of Galactic-Hf, A Ph3 Trial Of Omecamtiv Mecarbil
06 Feb 2020 //
PRESS RELEASE
Analysis counters concerns about Amgen heart failure drug
19 Nov 2019 //
FIERCE BIOTECH
Amgen Starts Phase III Enrollment for Heart Failure Drug
22 Feb 2019 //
NASDAQ
Amgen, Servier start second phase 3 trial of heart failure hope
22 Feb 2019 //
PMLIVE
MHRA issues drug safety warning for Neo-mercazole in pregnancy
22 Feb 2019 //
PHARMA TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.